TNFRSF1B
Tumor necrosis factor receptor superfamily member 1B
Also known as: CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80, TNR1B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20333
- Gene
- TNFRSF1B
- Ensembl
- ENSG00000028137
- Chromosome
- 1
- Canonical length
- 461 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein and TNF-receptor 1 form a heterocomplex that mediates the recruitment of two anti-apoptotic proteins, c-IAP1 and c-IAP2, which possess E3 ubiquitin ligase activity. The function of IAPs in TNF-receptor signalling is unknown, however, c-IAP1 is thought to potentiate TNF-induced apoptosis by the ubiquitination and degradation of TNF-receptor-associated factor 2, which mediates anti-apoptotic signals. Knockout studies in mice also suggest a role of this protein in protecting neurons from apoptosis by stimulating antioxidative pathways. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
461 residues, UniProt reviewed canonical sequence.
>P20333|TNFRSF1B
1 MAPVAVWAAL AVGLELWAAA HALPAQVAFT PYAPEPGSTC RLREYYDQTA QMCCSKCSPG
61 QHAKVFCTKT SDTVCDSCED STYTQLWNWV PECLSCGSRC SSDQVETQAC TREQNRICTC
121 RPGWYCALSK QEGCRLCAPL RKCRPGFGVA RPGTETSDVV CKPCAPGTFS NTTSSTDICR
181 PHQICNVVAI PGNASMDAVC TSTSPTRSMA PGAVHLPQPV STRSQHTQPT PEPSTAPSTS
241 FLLPMGPSPP AEGSTGDFAL PVGLIVGVTA LGLLIIGVVN CVIMTQVKKK PLCLQREAKV
301 PHLPADKARG TQGPEQQHLL ITAPSSSSSS LESSASALDR RAPTRNQPQA PGVEASGAGE
361 ARASTGSSDS SPGGHGTQVN VTCIVNVCSS SDHSSQCSSQ ASSTMGDTDS SPSESPKDEQ
421 VPFSKEECAF RSQLETPETL LGSTEEKPLP LGVPDAGMKP SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFRSF1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- appendix: 65 nTPM
- spleen: 50 nTPM
- bone marrow: 49 nTPM
- placenta: 34 nTPM
- adipose tissue: 33 nTPM
- lymph node: 30 nTPM
Single-cell type
- neutrophils: 1,140 nCPM
- monocytes: 898 nCPM
- macrophages: 321 nCPM
- cdc: 285 nCPM
- kupffer cells: 225 nCPM
- nk-cells: 219 nCPM
Immune cell
- non-classical monocyte: 388 nTPM
- intermediate monocyte: 260 nTPM
- total PBMC: 150 nTPM
- neutrophil: 138 nTPM
- classical monocyte: 127 nTPM
- myeloid DC: 72 nTPM
Brain region
- cerebral cortex: 44 nTPM
- medulla oblongata: 44 nTPM
- white matter: 34 nTPM
- pons: 28 nTPM
- thalamus: 25 nTPM
- hypothalamus: 24 nTPM
ReferencesPubMed · IEDB
Publications for TNFRSF1B from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- The transmembrane form of TNF-alpha drives autoantibody production in the absence of CD154: studies using MRL/Mp-Fas(lpr) mice.
2002 · Clin Exp Immunol · RCR 0.1 · 9 citations
Reference: B cellIEDB
1 publication
- Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination.
2017 · Int J Infect Dis · RCR 0.7 · 19 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.5
- gnomAD missense Z
- 0.93
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aortic valve development
- cellular response to lipopolysaccharide
- extrinsic apoptotic signaling pathway
- inflammatory response
- intrinsic apoptotic signaling pathway in response to DNA damage
- negative regulation of cardiac muscle hypertrophy
- negative regulation of extracellular matrix constituent secretion
- negative regulation of neuroinflammatory response
- positive regulation of apoptotic process involved in morphogenesis
- positive regulation of membrane protein ectodomain proteolysis
- positive regulation of myelination
- positive regulation of oligodendrocyte differentiation
- pulmonary valve development
- regulation of cytokine production involved in immune response
- regulation of myelination
- regulation of neuroinflammatory response
- regulation of T cell cytokine production
- regulation of T cell proliferation
- RNA destabilization
- tumor necrosis factor-mediated signaling pathway
- glial cell-neuron signaling
Molecular functions
- tumor necrosis factor binding
- tumor necrosis factor receptor activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TNFR/NGFR cysteine-rich region
- TNFR/NGFR cysteine-rich region
- Tumour necrosis factor receptor 1B
- Tumor necrosis factor receptor 1B, N-terminal
- TNF and chemokine receptor-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFRSF1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFRSF1B as an antibody target. Whether an autoantibody or antibody against TNFRSF1B could matter depends on whether native TNFRSF1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFRSF1B is annotated at the cell surface, where native TNFRSF1B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TNFRSF1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...